Approximately 2.3 million people worldwide are co-infected with both human immunodeficiency virus (HIV) and hepatitis C (HCV).
A recent study from the University of Bristol and the London School of Hygiene & Tropical Medicine found that approximately 2.3 million people around the world have co-infections of human immunodeficiency virus (HIV) and hepatitis C (HCV).
Before the study, scientists knew little about the full reach of HIV/HCV co-infections. This is the first worldwide study that has been conducted on the topic.
Out of the 2.3 million people with co-infections, more than half (1.3 million) qualify as people who inject drugs.
“Despite a systematic search of published and unpublished literature, estimates were identified in only 45 percent of countries and the study quality was variable,” Dr Lucy Platt, lead author and senior lecturer from the London School of Hygiene & Tropical Medicine, said. “Improvement in the surveillance of HCV and HIV is imperative to help define the epidemiology of co-infection and inform appropriate policies for testing, prevention, care and treatment to those in need. This is especially the case in countries with growing populations of (people who inject drugs) and also in sub-Saharan Africa where the burden of co-infection is large due to high burden of HIV.
Read Full Article: More than 2 million people have HIV and hepatitis C co-infections